share_log

公告精选 | 融创中国1月合同销售额同比下滑近5成;药明生物回购1349万股涉资2.33亿港元

Selected announcements | Sunac China's January contract sales fell by nearly 50% year on year; Pharmaceutical Biotech's repurchase of 13.49 million shares involved HK$233 million

Futu News ·  Feb 6 08:03

A selection of major announcements

1. Sunac China achieved contract sales of about 3.76 billion yuan in January, a year-on-year decrease of 47.99%

$SUNAC (01918.HK)$An announcement was issued. In January 2024, the Group achieved a contract sales amount of about RMB 3.76 billion, a year-on-year decrease of 47.99%; the contract sales area was about 325,000 square meters, and the average contract sales price was about RMB 1,1570 per square meter.

2. Agile Group: January pre-sale amount was 2.39 billion yuan, a year-on-year decrease of 62.89%

$AGILE GROUP (03383.HK)$According to the announcement, the total pre-sale amount for January 2024 was RMB 2.39 billion, a year-on-year decrease of 62.89%; the corresponding construction area was 166,000 square meters; the average price was RMB 14,411 per square meter.

3. Yao Ming Kangde completed a share repurchase of 1 billion yuan of A-shares

$WUXI APPTEC (02359.HK)$It was announced that on February 5, 2,0754 million A-shares were repurchased for the first time, with a price of 46.5-51.72 yuan per share, with a total capital of 1 billion yuan, or the maximum capital of the repurchase plan. So far, the share repurchase has been completed.

4. Pharmaceutical Biotech repurchased 13.49 million shares, involving HK$233 million

$WUXI BIO (02269.HK)$Announcement: On February 5, 13.493 million shares were repurchased on the Stock Exchange at a price of HK$16.9-17.82 per share, at a total cost of approximately HK$233 million. Since the adoption of the ordinary resolution, the company has repurchased a total of 58.353,500 shares, accounting for 1.37354% of the share capital.

Operational data

$SUNAC (01918.HK)$: Achieved contract sales amount of about 3.76 billion yuan in January

$AGILE GROUP (03383.HK)$: The total amount of pre-sales in January was 2.39 billion yuan

$ZHONGLIANG HLDG (02772.HK)$: January contract sales amount of 2.01 billion yuan

$SINO-OCEAN GP (03377.HK)$: January agreed sales of 1.2 billion yuan

$CONCORD NE (00182.HK)$: Total equity power generation in January was 756.24 GWh, up 17.16% year on year

$TRULY INT'L (00732.HK)$: Net consolidated revenue for January was HK$1,637 million, up 84.6% year on year

$HOPSON DEV HOLD (00754.HK)$: Total contract sales amount in January was 1,286 billion yuan

Increase or decrease holdings

$TIMES ELECTRIC (03898.HK)$: CRRC Zhuzhou, the controlling shareholder, increased its total A-share holdings by 1.415 million

Important matters

$SH PHARMA (02607.HK)$: The new specification of 15mg of nalidomide capsules was approved

$CHINASOUTHCITY (01668.HK)$: It is proposed to sell about 50% of First Asia Pacific's shares through public tender

Buyback News

$WUXI APPTEC (02359.HK)$On February 5, it spent about 1 billion yuan to buy back 202754 million A-shares

$WUXI BIO (02269.HK)$13.49 million shares were repurchased at HK$234 million on February 5

$AIA (01299.HK)$On February 5, it spent HK$796.17 million to buy back 1,319,800 shares

$XIAOMI-W (01810.HK)$4 million shares were repurchased at HK$48.68 million on February 5

$KINGDEE INT'L (00268.HK)$On February 5, 4.378 million shares were purchased at HK$32.812,400

$KUAISHOU-W (01024.HK)$Repurchase 401,400 shares at HK$15.75 million on February 5

$KINGSOFT (03888.HK)$Repurchase 304,400 shares at HK$5.72 million on February 5

Editor/Corrine

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment